Galectin Therapeutics Reports 2023 Financial Results and Provides Business UpdateNORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results...
Globe Newswire•4 months ago